Ottacef-S-1.5 for Powerful Infection Control

Ottacef-S-1.5 is a combination antibiotic injection containing 1000 mg of Ceftriaxone and 500 mg of Sulbactam, designed to treat a wide range of moderate to severe bacterial infections. This dual-action formulation enhances the effectiveness of Ceftriaxone by preventing bacterial resistance mechanisms.

How Ceftriaxone + Sulbactam Works

Ceftriaxone works by inhibiting bacterial cell wall synthesis, leading to the destruction of bacteria. However, some bacteria produce enzymes called beta-lactamases that can inactivate antibiotics. Sulbactam blocks these enzymes, allowing ceftriaxone to work more effectively against resistant strains.

Key Benefits of Ottacef-S-1.5

Ottacef-S-1.5 provides broad-spectrum antibacterial coverage and is effective in treating infections of the respiratory tract, urinary tract, skin, abdomen, and bloodstream. It is especially useful in hospital settings where infections may be severe or resistant. The combination ensures faster recovery, reduced bacterial resistance, and improved clinical outcomes.

Usage of Ottacef-S-1.5

This injection is administered intravenously (IV) or intramuscularly (IM) under the supervision of a qualified healthcare professional. The dosage and duration depend on the severity of the infection and the patient’s condition. Completing the full course is essential to prevent recurrence and resistance.

Ottacef-S-1.5 (Ceftriaxone 1000 mg + Sulbactam 500 mg) injection is a reliable and effective antibiotic choice for managing serious infections. Its dual mechanism ensures enhanced bacterial control, making it a preferred option in modern clinical practice.